Zacks Small Cap Research – RERE 1Q25 Earnings Review: EPS Strength Beneath the Surface; Rising Trade-In Activity Increasingly Driving Growth – Go Health Pro
By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 5/20/25, ATRenew (NYSE:RERE) reported 1Q25 earnings results. On a GAAP basis, RERE reported net income of $5.9 million for 1Q25, or $0.02 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.04, or … Read more